On Tuesday, Zydus Life shares closed at Rs 903.1, up 1.1% on the BSE, while the benchmark Sensex surged 1.53%. The stock has ...

The uptick in the Zydus Life shares came after the company received final approval from the USFDA to manufacture Eluxadoline Tablets, 75 mg and 100 mg ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered widespread caution over EPS dilution.

Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 mg & 100 mg) for IBS-D treatment. The company secured 180 days of shared ...

Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...

The company got the nod to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 ...

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...

March 11 (Reuters) - India's Zydus Lifesciences (ZYDU.NS), opens new tab said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA), opens new tab for 256.8 million ...

The near-term trigger for the stock is its plan to acquire Amplitude Surgical. Amplitude had a 5 per cent year-on-year (Y-o-Y) growth in sales for the six months ending in December’24, with an ...

Zydus Family Trust purchased a luxury apartment in Mumbai's Oberoi Realty project for ₹200 crore. Covering 17,384 sq ft, the ...

The specialty chemicals sector has faced headwinds over the past year, but Q4 FY25 shows signs of stabilisation ...

Zydus Life shares performance On Tuesday, Zydus Life shares closed at Rs 903.1, up 1.1% on the BSE, while the benchmark ...